Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.81 |
| ▸ | HPGD | P15428 | 5/20 | 0.81 |
| ▸ | MAOB | P27338 | 4/20 | 0.81 |
| ▸ | GAA | P10253 | 3/20 | 0.81 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.81 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.80 |
| ▸ | RAB9A | P51151 | 2/20 | 0.80 |
| ▸ | NPC1 | O15118 | 2/20 | 0.80 |
| ▸ | POLB | P06746 | 1/20 | 0.80 |
| ▸ | GLA | P06280 | 2/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.74 |
| ▸ | CA12 | O43570 | 2/20 | 0.71 |
| ▸ | CA2 | P00918 | 2/20 | 0.71 |
| ▸ | CA3 | P07451 | 2/20 | 0.71 |
| ▸ | CA6 | P23280 | 2/20 | 0.71 |
| ▸ | CA7 | P43166 | 2/20 | 0.71 |
| ▸ | CA9 | Q16790 | 2/20 | 0.71 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.71 |
| ▸ | CA4 | P22748 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2034492 | 0.91 | ALDH1A1 (0.85) | ALDH1A1HPGDMAOBGAASLC16A3 | |
| SCHEMBL1366230 | 0.91 | ALDH1A1 (0.81) | ALDH1A1HPGDMAOBGAASLC16A3 | |
| SCHEMBL5940585 | 0.89 | ALDH1A1 (0.66) | ALDH1A1HPGDMAOBGAASLC16A3 | |
| SCHEMBL1104931 | 0.89 | ALDH1A1 (1.00) | ALDH1A1HPGDMAOBGAASLC16A3 | |
| SCHEMBL203997 | 0.89 | SLC16A3 (1.00) | ALDH1A1HPGDMAOBGAASLC16A3 | |
| SCHEMBL51978 | 0.89 | ALDH1A1 (1.00) | ALDH1A1HPGDMAOBGAASLC16A3 | |
| SCHEMBL6836388 | 0.88 | ALDH1A1 (0.65) | ALDH1A1HPGDMAOBGAASLC16A3 | |
| SCHEMBL20918170 | 0.88 | ALDH1A1 (0.93) | ALDH1A1HPGDMAOBGAASLC16A3 | |
| SCHEMBL6687148 | 0.88 | MAOB (0.76) | ALDH1A1HPGDMAOBGAASLC16A3 | |
| SCHEMBL11829416 | 0.88 | ALDH1A1 (0.76) | ALDH1A1HPGDMAOBGAASLC16A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 574 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | claimed |
| US-10919909-B2 | Photoinitiated reactions | LINTFIELD LIMITED (GB) | 2021-02-16 | — | — | US | claimed |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | LINTFIELD LIMITED (GB) | 2019-07-11 | — | — | US | claimed |
| US-20190046463-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | ICURE PHARMACEUTICAL INC. (KR) | 2019-02-14 | — | — | US | claimed |
| EP-3415141-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | Icure Pharmaceutical Inc. (KR) | 2018-12-19 | — | — | EP | claimed |
| US-20100137468-A1 | DENTAL COMPOSITION BASED ON SILICONE CROSSLINKABLE BY CATION PROCESS | BLUESTAR SILICONES FRANCE (FR) | 2010-06-03 | — | — | US | claimed |
| US-7247660-B2 | Dental composition based on silicone crosslinkable by cation process | RHODIA CHIMIE (FR) | 2007-07-24 | — | — | US | claimed |
| US-20070149636-A1 | Dental composition based on silicone crosslinkable by cation process | FRANCES JEAN-MARC | 2007-06-28 | — | — | US | claimed |
| US-6747071-B1 | SILICON CROSSLINKABLE AND/OR POLYMERIZABLE BY CATION PROCESS, AN INITIATOR SUCH AS ONIUM BORATE, A PHOTOSENSITIZER AND A DENTAL FILLER, DENTAL PROSTHESES OR FOR DENTAL RESTORATION. | RHODIA CHIMIE (FR) | 2004-06-08 | — | — | US | claimed |
| EP-0616701-B1 | PHOTOCURABLE CYCLOBUTARENE COMPOSITIONS | DOW CHEMICAL CO (US) | 2002-02-13 | — | — | EP | claimed |
| EP-0022188-B1 | CO-INITIATOR COMPOSITIONS FOR PHOTOPOLYMERIZATION CONTAINING 3-ACYL-SUBSTITUTED COUMARINS, PHOTOPOLYMERIZABLE COMPOSITION AND PHOTOGRAPHIC ELEMENT | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1984-10-03 | — | — | EP | claimed |
| EP-0022188-A2 | Co-initiator compositions for photopolymerization containing 3-acyl-substituted coumarins, photopolymerizable composition and photographic element | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1981-01-14 | — | — | EP | claimed |
| US-4147552-A | Light-sensitive compositions with 3-substituted coumarin compounds as spectral sensitizers | EASTMAN KODAK COMPANY (US) | 1979-04-03 | — | — | US | claimed |
| EP-4743828-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4555025-B1 | PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS, FURTHER ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS | IGM GROUP B V (NL) | 2026-05-13 | — | — | EP | disclosed |
| EP-3902878-B1 | PHOTOINITIATORS | IGM RESINS ITALIA SRL (IT) | 2026-05-06 | — | — | EP | disclosed |
| EP-0332455-A2 | Photosensitive material and image forming method | CANON KABUSHIKI KAISHA (JP) | 1989-09-13 | — | — | EP | disclosed |
| EP-0328364-A2 | Photosensitive material | CANON KABUSHIKI KAISHA (JP) | 1989-08-16 | — | — | EP | disclosed |
| US-4366228-A | 3-KETOCOUMARIN DERIVATIVES AS PHOTOSENSITIZERS; ALPHA-PHENYLOXYALKYLENECARBOXYLIC ACIDS AS ACTIVATORS; HIGH SPEED | EASTMAN KODAK COMPANY (US) | 1982-12-28 | — | — | US | disclosed |
| US-4289844-A | 3-KETO-COUMARIN DERIVATIVES, HIGH SPEED | EASTMAN KODAK COMPANY (US) | 1981-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919909-B2 | Photoinitiated reactions | KMO, DECR1, PPOX | ALDH1A1 262/4885HPGD 237/4885MAOB 183/4885 |
| US-20100137468-A1 | DENTAL COMPOSITION BASED ON SILICONE CROSSLINKABLE BY CATION PROCESS | ALG3, TAS2R42, ITGB5 | ALDH1A1 3983/4885HPGD 824/4885MAOB 4030/4885 |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | DOHH, PAH, DBH | ALDH1A1 179/4885HPGD 704/4885MAOB 506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.